Lenacapavir |GS-6207

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Product Overview

Product Name	Lenacapavir (Synonyms: GS-6207)
CAS	2189684-44-2
Formula	C39H32ClF10N7O5S2
MW	968.28
Appearance	White to light yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Lenacapavir (GS-6207) is a novel, first-in-class,long-acting and highly potent HIV-1 capsid inhibitor approved in EU on August 22, 2022 to treat HIV patients infected with multidrug-resistant virus and as a twice-yearly injectable for pre-exposure prophylaxis.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2746

Lenacapavir (Synonyms: GS-6207)

2189684-44-2 98+%